Lipoprotein(a), type 2 diabetes and vascular risk in coronary patients

European Journal of Clinical Investigation

Volumn 36, Issue 2, 2006, Pages 91-97

  Saely, C H ^a,b   Koch, L ^a   Schmid, F ^a   Marte, T ^a,b   Aczel, S ^a,b   Langer, P ^a   Hoefle, G ^b   Drexel, H ^a,b,c  

^a Vorarlberg Institute for Vascular Investigation and Treatment VIVIT   (Austria)

^b ACADEMIC TEACHING HOSPITAL FELDKIRCH   (Austria)

^c VIVIT   (Austria)

Author keywords

Coronary angiography; Lipoprotein(a); Prospective study; Type 2 diabetes mellitus

Indexed keywords

LIPOPROTEIN A;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; VASCULAR DISEASE;

AGED; CHOLESTEROL; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LIPOPROTEIN(A); MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES; VASCULAR DISEASES;

EID: 33645085036     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2006.01604.x     Document Type: Article

References (45)

1. Utermann G The mysteries of lipoprotein(a) Science 1989 246 4932 904 10
2. Danesh J Collins R Peto R Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies Circulation 2000 102 10 1082 5
3. Zairis MN Ambrose JA Manousakis SJ Stefanidis AS Papadaki OA Bilianou HI et al. The impact of plasma levels of C-reactive protein, lipoprotein(a) and homocysteine on the long-term prognosis after successful coronary stenting: the Global Evaluation of New Events and Restenosis After Stent Implantation Study J Am Coll Cardiol 2002 40 8 1375 82
4. Berg K Dahlen G Christophersen B Cook T Kjekshus J Pedersen T Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study Clin Genet 1997 52 5 254 61
5. Stubbs P Seed M Lane D Collinson P Kendall F Noble M Lipoprotein(a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes Eur Heart J 1998 19 9 1355 64
6. Shlipak MG Simon JA Vittinghoff E Lin F Barrett-Connor E Knopp RH et al. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause JAMA 2000 283 14 1845 52
7. Glader CA Birgander LS Stenlund H Dahlen GH Is lipoprotein(a) a predictor for survival in patients with established coronary artery disease? Results from a prospective patient cohort study in northern Sweden J Intern Med 2002 252 1 27 35
8. Lundstam U Herlitz J Karlsson T Linden T Wiklund O Serum lipids, lipoprotein(a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease J Intern Med 2002 251 2 111 8
9. Skinner JS Farrer M Albers CJ Piper K Neil HA Adams PC Serum Lp(a) lipoprotein concentration is not associated with clinical and angiographic outcome five years after coronary artery bypass graft surgery Heart 1997 78 2 131 5
10. Linden T Taddei-Peters W Wilhelmsen L Herlitz J Karlsson T Ullstrom C et al. Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery Atherosclerosis 1998 137 1 175 86
11. Gazzaruso C Garzaniti A Falcone C Puija A Geroldi D Giordanetti S et al. Lipoprotein(a), apolipoprotein(a) polymorphism and restenosis after intracoronary stent placement in type 2 diabetic patients J Diabetes Complications 2003 17 3 135 40
12. Maser RE Usher D Becker DJ Drash AL Kuller LH Orchard TJ Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort Diabetes Care 1993 16 5 755 8
13. Haffner SM Moss SE Klein BE Klein R Lack of association between lipoprotein(a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy Metabolism 1992 41 2 194 7
14. Hiraga T Kobayashi T Okubo M Nakanishi K Sugimoto T Ohashi Y et al. Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes Diabetes Care 1995 18 2 241 4
15. Shai I Schulze MB Manson JE Stampfer MJ Rifai N Hu FB A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes Diabetologia 2005 48 8 1469 76
16. Nathan DM Meigs J Singer DE The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is... or is it? Lancet 1997 350 Suppl. 1 SI4 SI9
17. Drexel H Aczel S Marte T Benzer W Langer P Moll W et al. Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol? Diabetes Care 2005 28 1 101 7
18. Alberti KG Zimmet PZ Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 1998 15 7 539 53
19. Levey AS Bosch JP Lewis JB Greene T Rogers N Roth D A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 1999 130 6 461 70
20. Levey AS Greene T Kusek JW Beck GJ A simplified equation to predict glomerular filtration rate from serum creatinine J Am Soc Nephrol 2000 11 155A Ref type: Abstract
21. Chobanian AV Bakris GL Black HR Cushman WC Green LA Izzo JL et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 2003 289 19 2560 72
22. Drexel H Amann FW Beran J Rentsch K Candinas R Muntwyler J et al. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis Circulation 1994 90 5 2230 5
23. Carlson LA Hamsten A Asplund A Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid J Intern Med 1989 226 4 271 6
24. Jenkins AJ Steele JS Janus ED Santamaria JD Best JD Plasma apolipoprotein(a) is increased in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria Diabetologia 1992 35 11 1055 9
25. Heller FR Jamart J Honore P Derue G Novik V Galanti L et al. Serum lipoprotein(a) in patients with diabetes mellitus Diabetes Care 1993 16 5 819 23
26. Csaszar A Dieplinger H Sandholzer C Karadi I Juhasz E Drexel H et al. Plasma lipoprotein(a) concentration and phenotypes in diabetes mellitus Diabetologia 1993 36 1 47 51
27. Haffner SM Morales PA Stern MP Gruber MK Lp(a) concentrations in NIDDM Diabetes 1992 41 10 1267 72
28. Rainwater DL MacCluer JW Stern MP VandeBerg JL Haffner SM Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size Diabetes 1994 43 7 942 6
29. Gazzaruso C Garzaniti A Falcone C Geroldi D Finardi G Fratino P Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in type 2 diabetic patients and in non-diabetic subjects Diabet Med 2001 18 7 589 94
30. Widmann MD Sumpio BE Lipoprotein(a): a risk factor for peripheral vascular disease Ann Vasc Surg 1993 7 5 446 51
31. Maca TH Ahmadi R Derfler K Ehringer H Gschwandtner ME Horl W et al. Influence of lipoprotein(a) on restenosis after femoropopliteal percutaneous transluminal angioplasty in type 2 diabetic patients Diabet Med 2002 19 4 300 6
32. Seed M Hoppichler F Reaveley D McCarthy S Thompson GR Boerwinkle E et al. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia N Engl J Med 1990 322 21 1494 9
33. Hernandez C Chacon P Garcia-Pascual L Simo R Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) concentrations in diabetic patients Diabetes Care 2001 24 2 350 5
34. Ruiz J Thillet J Huby T James RW Erlich D Flandre P et al. Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes Diabetologia 1994 37 6 585 91
35. Watts GF ap Gwilym RM Mazurkiewicz J Coltart J Independent correlation between plasma lipoprotein(a) and angiographic coronary artery disease in NIDDM Diabetes Care 1995 18 2 234 6
36. Comlekci A Biberoglu S Kozan O Bahceci O Ergene O Nazli C et al. Correlation between serum lipoprotein(a) and angiographic coronary artery disease in non-insulin-dependent diabetes mellitus J Intern Med 1997 242 6 449 54
37. Mohan V Deepa R Haranath SP Premalatha G Rema M Sastry NG et al. Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in south India Diabetes Care 1998 21 11 1819 23
38. Gazzaruso C Bruno R Pujia A De Amici E Fratino P Solerte SB et al. Lipoprotein(a), apolipoprotein(a) polymorphism and coronary atherosclerosis severity in type 2 diabetic patients Int J Cardiol 2005 June 13 (Epub ahead of print)
39. O'Brien T Nguyen TT Harrison JM Bailey KR Dyck PJ Kottke BA Lipids and Lp(a) lipoprotein levels and coronary artery disease in subjects with non-insulin-dependent diabetes mellitus Mayo Clin Proc 1994 69 5 430 5
40. Relimpio F Pumar A Losada F Montilla C Morales F Acosta D et al. Lack of association of lipoprotein(a) with coronary heart disease in Spaniard type 2 diabetic patients Diabetes Res Clin Pract 1997 35 2-3 135 41
41. Abdella NA Mojiminiyi OA Akanji AO Al Mohammadi H Moussa MA Serum lipoprotein(a) concentration as a cardiovascular risk factor in Kuwaiti type 2 diabetic patients J Diabetes Complications 2001 15 5 270 6
42. Saely CH Aczel S Marte T Langer P Hoefle G Drexel H The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients J Clin Endocrinol Metab 2005 90 10 5698 703
43. Stein JH Rosenson RS Lipoprotein Lp(a) excess and coronary heart disease Arch Intern Med 1997 157 11 1170 6
44. Maher VM Brown BG Marcovina SM Hillger LA Zhao XQ Albers JJ Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a) JAMA 1995 274 22 1771 4
45. Haffner SM Dyslipidemia management in adults with diabetes Diabetes Care 2004 27 Suppl. 1 S68 S71